The Interplay Between COVID-19 and Spondyloarthritis or Its Treatment.
James Todd RosenbaumMichael H WeismanHedley HamiltonCassie ShaferElin AslanyanRichard A HowardKimberly OgleJohn D ReveilleKevin L WinthropDongseok ChoiPublished in: The Journal of rheumatology (2021)
These data do not exclude a small increased risk of developing COVID-19 as a result of SpA, but the risk, if it exists, is low and not consistently demonstrated. The data should provide reassurance to patients and to rheumatologists about the risk that COVID-19 poses to patients with SpA.
Keyphrases
- coronavirus disease
- sars cov
- end stage renal disease
- electronic health record
- ejection fraction
- chronic kidney disease
- big data
- newly diagnosed
- respiratory syndrome coronavirus
- peritoneal dialysis
- prognostic factors
- machine learning
- patient reported outcomes
- disease activity
- artificial intelligence
- patient reported
- deep learning